We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biodegradable Nanoparticles Kill Drug Resistant Gram-Positive Bacteria

By LabMedica International staff writers
Posted on 20 Apr 2011
A recent paper described the development of biodegradable nanoparticles capable of killing Gram-positive bacteria including MRSA (Methicillin-resistant Staphylococcus aureus).

Investigators at the IBM Almaden Research Laboratory (San Jose, CA, USA) focused on types of nanoparticles that would be able to disrupt bacterial cell membranes. More...
They reasoned that while it only requires one to two decades for microbes to develop resistance to traditional antibiotics that target a particular metabolic pathway inside the cell, drugs that compromise microbes' cell membranes are probably less likely to evoke resistance.

In the current study, they prepared polymer nanoparticles synthesized by metal-free organocatalytic ring-opening polymerization of functional cyclic carbonate. These nanoparticles were biodegradable and possessed a secondary structure that could insert into and disintegrate bacterial and fungal cell membranes.

Data obtained in collaboration with researchers at the Singapore Institute of Bioengineering and Nanotechnology (Singapore) was published in the April 3, 2011, online edition of the journal Nature Chemistry. Results showed that the nanoparticles disrupted microbial walls and membranes selectively and efficiently, thus inhibiting the growth of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and fungi, without inducing significant hemolysis over a wide range of concentrations.

The biodegradable nanoparticles, which can be synthesized in large quantities and at low cost, represent a promising new class of antimicrobial drugs.

"We are trying to generate polymers that interact with microbes in a very different way than traditional antibiotics,” said contributing author Dr. James Hedrick, a materials scientist at the IBM Almaden Research Laboratory.

Related Links:
IBM Almaden Research Laboratory
Singapore Institute of Bioengineering and Nanotechnology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.